Detail of the clinical trial

Title of the trial A phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare Efficacy and Safety of Oral Azacitidine plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Subjects with Acute Myeloid Leukemia in Complete Remission
EudraCT number 2012-003457-28
Protocol number CC-486-AML-001
Sponsor Celgene Corporation,86 Morris Avenue,Summit, NJ,07901
Indications Hemato-oncology
Diagnosis Acute Myeloid Leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2012
Date of approval by Institute (SÚKL) 21.1.2013
Date of approval by EC 18.4.2013
Date of initiation CT in ČR 8.7.2014
Date of ending CT in ČR
Sites FN Brno,Interní hematoonkologická klinika,Jihlavská 20,Brno,625 00
Ústav hematologie a krevní transfúze,,U Nemocnice 1,Praha 2,128 20
Všeobecná fakultní nemocnice v Praze,I. interní klinika - klinika hematologie,U Nemocnice 2,Praha,128 08 (discontinued)

‹‹ Back to list